|
Volume 270,
Number 44,
Issue of November 3, 1995 pp. 26607-26612
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Cortisol
Increases Interstitial Collagenase Expression in Osteoblasts by
Post-transcriptional Mechanisms
(Received for publication, December 14, 1994; and in revised form, June 30, 1995)
Anne M.
Delany ,
John J.
Jeffrey,
Sheila
Rydziel ,
Ernesto
Canalis
Glucocorticoids regulate both bone formation and bone
resorption. In osteoblasts, they inhibit type I collagen synthesis;
however, there is limited information about their effects on
interstitial collagenase, the enzyme that degrades type I collagen. We
used primary cultures of osteoblast-enriched cells from fetal rat
calvariae (Ob cells) to study the effects of cortisol on collagenase
expression. Northern blot analysis showed that cortisol increased
collagenase transcript levels in a dose- and time-dependent manner,
which was paralleled by an increase in immunoreactive metalloproteinase
in the culture medium. Cortisol increased the half-life of collagenase
mRNA from 6 to 12 h in transcription-arrested Ob cells. In contrast,
cortisol modestly decreased collagenase gene transcription after 24 h
of treatment. The up-regulation of collagenase by cortisol is
osteoblast-specific, since the glucocorticoid decreased phorbol
12-myristate 13-acetate-induced collagenase mRNA expression in rat
fibroblasts, a result that agrees with other studies of collagenase
gene regulation in fibroblastic cells. In conclusion, cortisol
increases interstitial collagenase transcript levels by
post-transcriptional mechanisms in osteoblastic cells. Our data
demonstrate that glucocorticoids regulate collagenase gene expression
in a novel tissue-specific manner, further highlighting the differences
in gene regulation between osteoblastic and fibroblastic cells.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Jarvelainen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Pharmacol. Rev.,
June 1, 2009;
61(2):
198 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rydziel, A. M. Delany, and E. Canalis
AU-Rich Elements in the Collagenase 3 mRNA Mediate Stabilization of the Transcript by Cortisol in Osteoblasts
J. Biol. Chem.,
February 13, 2004;
279(7):
5397 - 5404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Luppen, N. Leclerc, T. Noh, A. Barski, A. Khokhar, A. L. Boskey, E. Smith, and B. Frenkel
Brief Bone Morphogenetic Protein 2 Treatment of Glucocorticoid-inhibited MC3T3-E1 Osteoblasts Rescues Commitment-associated Cell Cycle and Mineralization without Alteration of Runx2
J. Biol. Chem.,
November 7, 2003;
278(45):
44995 - 45003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yu, S. J. Cok, C. Zeng, and A. R. Morrison
Translational Repression of Human Matrix Metalloproteinases-13 by an Alternatively Spliced Form of T-cell-restricted Intracellular Antigen-related Protein (TIAR)
J. Biol. Chem.,
January 10, 2003;
278(3):
1579 - 1584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Onodera, J. Nishihira, K. Iwabuchi, Y. Koyama, K. Yoshida, S. Tanaka, and A. Minami
Macrophage Migration Inhibitory Factor Up-regulates Matrix Metalloproteinase-9 and -13 in Rat Osteoblasts. RELEVANCE TO INTRACELLULAR SIGNALING PATHWAYS
J. Biol. Chem.,
March 1, 2002;
277(10):
7865 - 7874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Canalis and A. Giustina
Glucocorticoid-Induced Osteoporosis: Summary of a Workshop
J. Clin. Endocrinol. Metab.,
December 1, 2001;
86(12):
5681 - 5685.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Delany, D. Durant, and E. Canalis
Glucocorticoid Suppression of IGF I Transcription in Osteoblasts
Mol. Endocrinol.,
October 1, 2001;
15(10):
1781 - 1789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Blanquaert, R. C. Pereira, and E. Canalis
Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts
Am J Physiol Endocrinol Metab,
March 1, 2000;
278(3):
E509 - E515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dennison, P. Hindmarsh, C. Fall, S. Kellingray, D. Barker, D. Phillips, and C. Cooper
Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men
J. Clin. Endocrinol. Metab.,
September 1, 1999;
84(9):
3058 - 3063.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. M. Delany and E. Canalis
Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in Murine Osteoblasts
J. Biol. Chem.,
June 26, 1998;
273(26):
16595 - 16600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rubin, D. M. Biskobing, L. Jadhav, D. Fan, M. S. Nanes, S. Perkins, and X. Fan
Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells
Endocrinology,
March 1, 1998;
139(3):
1006 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Franchimont, S. Rydziel, A. M. Delany, and E. Canalis
Interleukin-6 and Its Soluble Receptor Cause a Marked Induction of Collagenase 3 Expression in Rat Osteoblast Cultures
J. Biol. Chem.,
May 2, 1997;
272(18):
12144 - 12150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Lian, V. Shalhoub, F. Aslam, B. Frenkel, J. Green, M. Hamrah, G. S. Stein, and J. L. Stein
Species-Specific Glucocorticoid and 1,25-Dihydroxyvitamin D Responsiveness in Mouse MC3T3-E1 Osteoblasts: Dexamethasone Inhibits Osteoblast Differentiation and Vitamin D Down-Regulates Osteocalcin Gene Expression
Endocrinology,
May 1, 1997;
138(5):
2117 - 2127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gabbitas, J. M. Pash, A. M. Delany, and E. Canalis
Cortisol Inhibits the Synthesis of Insulin-like Growth Factor-binding Protein-5 in Bone Cell Cultures by Transcriptional Mechanisms
J. Biol. Chem.,
April 12, 1996;
271(15):
9033 - 9038.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|